720 ILCS 570/102
2021 Illinois Compiled Statutes|Chapter 720 - CRIMINAL OFFENSES|720 ILCS 570/ - Illinois Controlled Substances Act.|Article I

 (from Ch. 56 1/2, par. 1102)(Text of Section from P.A. 101-666)Sec. 102. Definitions.   As used in this Act, unless the context  otherwise requires:(a) "Addict" means any person who habitually uses any drug, chemical,  substance or dangerous drug other than alcohol so as to endanger the public  morals, health, safety or welfare or who is so far addicted to the use of a  dangerous drug or controlled substance other than alcohol as to have lost  the power of self control with reference to his or her addiction.(b) "Administer" means the direct application of a controlled  substance, whether by injection, inhalation, ingestion, or any other  means, to the body of a patient, research subject, or animal (as  defined by the Humane Euthanasia in Animal Shelters Act) by:(1) a practitioner (or, in his or her presence, by     his or her authorized agent),(2) the patient or research subject pursuant to an       order, or(3) a euthanasia technician as defined by the Humane     Euthanasia in Animal Shelters Act.(c) "Agent" means an authorized person who acts on behalf of or at  the direction of a manufacturer, distributor, dispenser, prescriber, or practitioner.  It does not  include a common or contract carrier, public warehouseman or employee of  the carrier or warehouseman.(c-1) "Anabolic Steroids" means any drug or hormonal substance,  chemically and pharmacologically related to testosterone (other than  estrogens, progestins, corticosteroids, and dehydroepiandrosterone),  and includes:(i) 3[beta],17-dihydroxy-5a-androstane,(ii) 3[alpha],17[beta]-dihydroxy-5a-androstane,(iii) 5[alpha]-androstan-3,17-dione,(iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(v) 1-androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(vi) 4-androstenediol(3[beta],17[beta]-dihydroxy-androst-4-ene),(vii) 5-androstenediol(3[beta],17[beta]-dihydroxy-androst-5-ene),(viii) 1-androstenedione([5alpha]-androst-1-en-3,17-dione),(ix) 4-androstenedione(androst-4-en-3,17-dione),(x) 5-androstenedione(androst-5-en-3,17-dione),(xi) bolasterone (7[alpha],17a-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xii) boldenone (17[beta]-hydroxyandrost-1,4,-diene-3-one),(xiii) boldione (androsta-1,4-diene-3,17-dione),(xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one),(xvi) dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-methyl-androst-1,4-dien-3-one),(xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol)(a.k.a., madol),(xviii) [delta]1-dihydrotestosterone (a.k.a.'1-testosterone') (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one),(xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one),(xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene),(xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl-1[beta],17[beta]-dihydroxyandrost-4-en-3-one),(xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one),(xxiv) furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan),(xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one,(xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy-androst-4-en-3-one),(xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxy-estr-4-en-3-one),(xxviii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5-androstan-3-one),(xxix) mesterolone (1amethyl-17[beta]-hydroxy-[5a]-androstan-3-one),(xxx) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one),(xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene),(xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xxxiii) 17[alpha]-methyl-3[beta], 17[beta]-dihydroxy-5a-androstane,(xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane,(xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene),(xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one),(xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one),(xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one),(xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one),(xl) mibolerone (7[alpha],17a-dimethyl-17[beta]-hydroxyestr-4-en-3-one),(xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone(17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl-1-testosterone'),(xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one),(xliii) 19-nor-4-androstenediol (3[beta], 17[beta]-dihydroxyestr-4-ene),(xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]-dihydroxyestr-4-ene),(xlv) 19-nor-5-androstenediol (3[beta], 17[beta]-dihydroxyestr-5-ene),(xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]-dihydroxyestr-5-ene),(xlvii) 19-nor-4,9(10)-androstadienedione(estra-4,9(10)-diene-3,17-dione),(xlviii) 19-nor-4-androstenedione (estr-4-en-3,17-dione),(xlix) 19-nor-5-androstenedione (estr-5-en-3,17-dione),(l) norbolethone (13[beta], 17a-diethyl-17[beta]-hydroxygon-4-en-3-one),(li) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one),(lii) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one),(liii) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one),(liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one),(lv) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one),(lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-(5[alpha]-androstan-3-one),(lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy-(5[alpha]-androst-2-eno[3,2-c]-pyrazole),(lviii) stenbolone (17[beta]-hydroxy-2-methyl-(5[alpha]-androst-1-en-3-one),(lix) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oicacid lactone),(lx) testosterone (17[beta]-hydroxyandrost-4-en-3-one),(lxi) tetrahydrogestrinone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one),(lxii) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one).Any person who is otherwise lawfully in possession of an anabolic  steroid, or who otherwise lawfully manufactures, distributes, dispenses,  delivers, or possesses with intent to deliver an anabolic steroid, which  anabolic steroid is expressly intended for and lawfully allowed to be  administered through implants to livestock or other nonhuman species, and  which is approved by the Secretary of Health and Human Services for such  administration, and which the person intends to administer or have  administered through such implants, shall not be considered to be in  unauthorized possession or to unlawfully manufacture, distribute, dispense,  deliver, or possess with intent to deliver such anabolic steroid for  purposes of this Act.(d) "Administration" means the Drug Enforcement Administration,  United States Department of Justice, or its successor agency.(d-5) "Clinical Director, Prescription Monitoring Program" means a Department of Human Services administrative employee licensed to either prescribe or dispense controlled substances who shall run the clinical aspects of the Department of Human Services Prescription Monitoring Program and its Prescription Information Library.(d-10) "Compounding" means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber's prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing. "Compounding" includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns. Commercially available products may be compounded for dispensing to individual patients only if both of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient's needs and (ii) the prescribing practitioner has requested that the drug be compounded.(e) "Control" means to add a drug or other substance, or immediate  precursor, to a Schedule  whether by  transfer from another Schedule or otherwise.(f) "Controlled Substance" means (i) a drug, substance, immediate  precursor, or synthetic drug in the Schedules of Article II of this Act or (ii) a drug or other substance, or immediate precursor, designated as a controlled substance by the Department through administrative rule. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are  defined or used in the Liquor Control Act of 1934 and the Tobacco Products Tax  Act of 1995.(f-5) "Controlled substance analog" means a substance:(1) the chemical structure of which is substantially     similar to the chemical structure of a controlled substance in Schedule I or II;(2) which has a stimulant, depressant, or     hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or(3) with respect to a particular person, which such     person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II.(g) "Counterfeit substance" means a controlled substance, which, or  the container or labeling of which, without authorization bears the  trademark, trade name, or other identifying mark, imprint, number or  device, or any likeness thereof, of a manufacturer, distributor, or  dispenser other than the person who in fact manufactured, distributed,  or dispensed the substance.(h) "Deliver" or "delivery" means the actual, constructive or  attempted transfer of possession of a controlled substance, with or  without consideration, whether or not there is an agency relationship.(i) "Department" means the Illinois Department of Human Services (as  successor to the Department of Alcoholism and Substance Abuse) or its successor agency.(j) (Blank).(k) "Department of Corrections" means the Department of Corrections  of the State of Illinois or its successor agency.(l) "Department of Financial and Professional Regulation" means the Department  of Financial and Professional Regulation of the State of Illinois or its successor agency.(m) "Depressant"  means any drug that (i) causes an overall depression of central nervous system functions, (ii) causes impaired consciousness and awareness,  and (iii) can be habit-forming or  lead to a substance abuse  problem, including but not limited to alcohol, cannabis and its active principles and their analogs, benzodiazepines and their analogs, barbiturates and  their analogs, opioids (natural and synthetic) and their analogs, and chloral hydrate and similar sedative hypnotics.(n) (Blank).(o) "Director" means the Director of the Illinois  State Police  or his or her designated agents.(p) "Dispense" means to deliver a controlled substance to an  ultimate user or research subject by or pursuant to the lawful order of  a prescriber, including the prescribing, administering, packaging,  labeling, or compounding necessary to prepare the substance for that  delivery.(q) "Dispenser" means a practitioner who dispenses.(r) "Distribute" means to deliver, other than by administering or  dispensing, a controlled substance.(s) "Distributor" means a person who distributes.(t) "Drug" means (1) substances recognized as drugs in the official  United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the  United States, or official National Formulary, or any supplement to any  of them; (2) substances intended for use in diagnosis, cure, mitigation,  treatment, or prevention of disease in man or animals; (3) substances  (other than food) intended to affect the structure of any function of  the body of man or animals and (4) substances intended for use as a  component of any article specified in clause (1), (2), or (3) of this  subsection.  It does not include devices or their components, parts, or  accessories.(t-3)  "Electronic health record" or "EHR" means an electronic record of health-related information on an individual that is created, gathered, managed, and consulted by authorized health care clinicians and staff.(t-3.5)       "Electronic health record system" or "EHR system" means any computer-based system or combination of federally certified Health IT Modules (defined at 42 CFR 170.102 or its successor) used as a repository for electronic health records and accessed or updated by a prescriber or authorized surrogate in the ordinary course of his or her medical practice.  For purposes of connecting to the Prescription Information Library maintained by the Bureau of Pharmacy and Clinical Support Systems or its successor, an EHR system may connect to the Prescription Information Library directly or through all or part of a computer program or system that is a federally certified Health IT Module maintained by a third party and used by the EHR system to secure access to the database.(t-4) "Emergency medical services personnel" has the meaning ascribed to it in the Emergency Medical Services (EMS) Systems Act.(t-5) "Euthanasia agency" means  an entity certified by the Department of Financial and Professional Regulation for the  purpose of animal euthanasia that holds an animal control facility license or  animal  shelter license under the Animal Welfare Act.  A euthanasia agency is  authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and  Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.(t-10) "Euthanasia drugs" means Schedule II or Schedule III substances  (nonnarcotic controlled substances) that are used by a euthanasia agency for  the purpose of animal euthanasia.(u) "Good faith" means the prescribing or dispensing of a controlled  substance by a practitioner in the regular course of professional  treatment to or for any person who is under his or her treatment for a  pathology or condition other than that individual's physical or  psychological dependence upon or addiction to a controlled substance,  except as provided herein:  and application of the term to a pharmacist  shall mean the dispensing of a controlled substance pursuant to the  prescriber's order which in the professional judgment of the pharmacist  is lawful.  The pharmacist shall be guided by accepted professional  standards including, but not limited to the following, in making the  judgment:(1) lack of consistency of prescriber-patient      relationship,(2) frequency of prescriptions for same drug by one     prescriber for large numbers of patients,(3) quantities beyond those normally prescribed,(4) unusual dosages (recognizing that there may be     clinical circumstances where more or less than the usual dose may be used legitimately),(5) unusual geographic distances between patient,     pharmacist and prescriber,(6) consistent prescribing of habit-forming drugs.(u-0.5) "Hallucinogen" means a drug that causes markedly altered sensory perception leading to hallucinations of any type.(u-1) "Home infusion services" means services provided by a pharmacy in  compounding solutions for direct administration to a patient in a private  residence, long-term care facility, or hospice setting by means of parenteral,  intravenous, intramuscular, subcutaneous, or intraspinal infusion.(u-5) "Illinois State Police" means the State  Police of the State of Illinois, or its successor agency.(v) "Immediate precursor" means a substance:(1) which the Department has found to be and by rule     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;(2) which is an immediate chemical intermediary used     or likely to be used in the manufacture of such controlled substance; and(3) the control of which is necessary to prevent,     curtail or limit the manufacture of such controlled substance.(w) "Instructional activities" means the acts of teaching, educating  or instructing by practitioners using controlled substances within  educational facilities approved by the State Board of Education or  its successor agency.(x) "Local authorities" means a duly organized State, County or  Municipal peace unit or police force.(y) "Look-alike substance" means a substance, other than a controlled  substance which (1) by overall dosage unit appearance, including shape,  color, size, markings or lack thereof, taste, consistency, or any other  identifying physical characteristic of the substance, would lead a reasonable  person to believe that the substance is a controlled substance, or (2) is  expressly or impliedly represented to be a controlled substance or is  distributed under circumstances which would lead a reasonable person to  believe that the substance is a controlled substance. For the purpose of  determining whether the representations made or the circumstances of the  distribution would lead a reasonable person to believe the substance to be  a controlled substance under this clause (2) of subsection (y), the court or  other authority may consider the following factors in addition to any other  factor that may be relevant:(a) statements made by the owner or person in control     of the substance concerning its nature, use or effect;(b) statements made to the buyer or recipient that     the substance may be resold for profit;(c) whether the substance is packaged in a manner     normally used for the illegal distribution of controlled substances;(d) whether the distribution or attempted     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.Clause (1) of this subsection (y) shall not apply to a noncontrolled  substance in its finished dosage form that was initially introduced into  commerce prior to the initial introduction into commerce of a controlled  substance in its finished dosage form which it may substantially resemble.Nothing in this subsection (y) prohibits the dispensing or distributing  of noncontrolled substances by persons authorized to dispense and  distribute controlled substances under this Act, provided that such action  would be deemed to be carried out in good faith under subsection (u) if the  substances involved were controlled substances.Nothing in this subsection (y) or in this Act prohibits the manufacture,  preparation, propagation, compounding, processing, packaging, advertising  or distribution of a drug or drugs by any person registered pursuant to  Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).(y-1) "Mail-order pharmacy" means a pharmacy that is located in a state  of the United States that delivers, dispenses or  distributes, through the United States Postal Service or other common  carrier, to Illinois residents, any substance which requires a prescription.(z) "Manufacture" means the production, preparation, propagation,  compounding, conversion or processing of a controlled substance  other than methamphetamine, either  directly or indirectly, by extraction from substances of natural origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis, and includes any packaging or  repackaging of the substance or labeling of its container, except that  this term does not include:(1) by an ultimate user, the preparation or     compounding of a controlled substance for his or her own use; or(2) by a practitioner, or his or her authorized agent     under his or her supervision, the preparation, compounding, packaging, or labeling of a controlled substance:(a) as an incident to his or her administering or         dispensing of a controlled substance in the course of his or her professional practice; or(b) as an incident to lawful research, teaching         or chemical analysis and not for sale.(z-1) (Blank).(z-5) "Medication shopping" means the conduct prohibited under subsection (a) of Section 314.5 of this Act.(z-10) "Mid-level practitioner" means (i) a physician assistant who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches, in accordance with Section 7.5 of the Physician Assistant Practice Act of 1987, (ii) an advanced practice registered nurse who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches or by a podiatric physician,  in accordance with Section 65-40 of the Nurse Practice Act, (iii)  an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act, (iv) an animal euthanasia agency, or (v) a prescribing psychologist.(aa) "Narcotic drug" means any of the following, whether produced  directly or indirectly by extraction from substances of vegetable  origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis:(1) opium, opiates, derivatives of opium and opiates,     including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; however the term "narcotic drug" does not include the isoquinoline alkaloids of opium;(2) (blank);(3) opium poppy and poppy straw;(4) coca leaves, except coca leaves and extracts of     coca leaves from which substantially all of the cocaine and  ecgonine, and their isomers, derivatives and salts, have been removed;(5) cocaine, its salts, optical and geometric     isomers, and salts of isomers;(6) ecgonine, its derivatives, their salts, isomers,     and salts of isomers;(7) any compound, mixture, or preparation which     contains any quantity of any of the substances referred to in subparagraphs (1) through (6).(bb) "Nurse" means a registered nurse licensed under the  Nurse Practice Act.(cc) (Blank).(dd) "Opiate" means any substance having an addiction forming or  addiction sustaining liability similar to morphine or being capable of  conversion into a drug having addiction forming or addiction sustaining  liability.(ee) "Opium poppy" means the plant of the species Papaver  somniferum L., except its seeds.(ee-5) "Oral dosage" means  a tablet, capsule, elixir, or solution or other liquid form of medication intended for administration by mouth, but the term does not include a form of medication intended for buccal, sublingual, or transmucosal administration.(ff) "Parole and Pardon Board" means the Parole and Pardon Board of  the State of Illinois or its successor agency.(gg) "Person" means any individual, corporation, mail-order pharmacy,  government or governmental subdivision or agency, business trust, estate,  trust, partnership or association, or any other entity.(hh) "Pharmacist" means any person who holds a license or certificate of  registration as a registered pharmacist, a local registered pharmacist  or a registered assistant pharmacist under the Pharmacy Practice Act.(ii) "Pharmacy" means any store, ship or other place in which  pharmacy is authorized to be practiced under the Pharmacy Practice Act.(ii-5) "Pharmacy shopping" means the conduct prohibited under subsection (b) of Section 314.5 of this Act.(ii-10) "Physician" (except when the context otherwise requires)   means a person licensed to practice medicine in all of its branches.(jj) "Poppy straw" means all parts, except the seeds, of the opium  poppy, after mowing.(kk) "Practitioner" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, podiatric physician,  veterinarian, scientific investigator, pharmacist, physician assistant,  advanced practice registered nurse,  licensed practical  nurse, registered nurse, emergency medical services personnel, hospital, laboratory, or pharmacy, or other  person licensed, registered, or otherwise lawfully permitted by the  United States or this State to distribute, dispense, conduct research  with respect to, administer or use in teaching or chemical analysis, a  controlled substance in the course of professional practice or research.(ll) "Pre-printed prescription" means a written prescription upon which  the designated drug has been indicated prior to the time of issuance; the term  does not mean a written prescription that is individually generated by  machine or computer in the prescriber's office.(mm) "Prescriber" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, podiatric physician, or  veterinarian who issues a prescription, a physician assistant who  issues a  prescription for a controlled substance  in accordance  with Section 303.05, a written delegation, and a written collaborative agreement required under Section 7.5  of the  Physician Assistant Practice Act of 1987, an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation,  and a written  collaborative agreement under Section 65-35 of the Nurse Practice Act, an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05, or an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn) "Prescription" means a  written, facsimile, or oral  order, or an electronic order that complies with applicable federal requirements,  of  a physician licensed to practice medicine in all its branches,  dentist, podiatric physician or veterinarian for any controlled  substance, of an optometrist in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, of a physician assistant for a  controlled substance  in accordance with Section 303.05, a written delegation, and a written collaborative agreement required under  Section 7.5 of the  Physician Assistant Practice Act of 1987, of an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act who issues a prescription for a  controlled substance in accordance  with  Section 303.05, a written delegation, and a written collaborative agreement under Section 65-35  of the Nurse Practice Act, of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05 when required by law, or of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn-5) "Prescription Information Library" (PIL) means an electronic library that contains reported controlled substance data.(nn-10) "Prescription Monitoring Program" (PMP) means the entity that collects, tracks, and stores reported data on controlled substances and select drugs pursuant to Section 316.(oo) "Production" or "produce" means manufacture, planting,  cultivating, growing, or harvesting of a controlled substance other than methamphetamine.(pp) "Registrant" means every person who is required to register  under Section 302 of this Act.(qq) "Registry number" means the number assigned to each person  authorized to handle controlled substances under the laws of the United  States and of this State.(qq-5) "Secretary" means, as the context requires, either the Secretary of the Department or the Secretary of the Department of Financial and Professional Regulation, and the Secretary's designated agents.(rr) "State" includes the State of Illinois and any state, district,  commonwealth, territory, insular possession thereof, and any area  subject to the legal authority of the United States of America.(rr-5) "Stimulant" means any drug that (i) causes an overall excitation of central nervous system functions,  (ii) causes impaired consciousness and awareness, and (iii) can be habit-forming or lead to a substance abuse problem, including but not limited to amphetamines and their analogs, methylphenidate and its analogs, cocaine, and phencyclidine and its analogs.(rr-10) "Synthetic drug" includes, but is not limited to, any synthetic cannabinoids or piperazines or any synthetic  cathinones as provided for in Schedule I.(ss) "Ultimate user" means a person who lawfully possesses a  controlled substance for his or her own use or for the use of a member of his or her  household or for administering to an animal owned by him or her or by a member  of his or her household.    (Source: P.A. 100-280, eff. 1-1-18; 100-453, eff. 8-25-17; 100-513, eff. 1-1-18; 100-789, eff. 1-1-19; 100-863, eff. 8-14-18; 101-666, eff. 1-1-22.)(Text of Section from P.A. 102-389)Sec. 102. Definitions.   As used in this Act, unless the context  otherwise requires:(a) "Addict" means any person who habitually uses any drug, chemical,  substance or dangerous drug other than alcohol so as to endanger the public  morals, health, safety or welfare or who is so far addicted to the use of a  dangerous drug or controlled substance other than alcohol as to have lost  the power of self control with reference to his or her addiction.(b) "Administer" means the direct application of a controlled  substance, whether by injection, inhalation, ingestion, or any other  means, to the body of a patient, research subject, or animal (as  defined by the Humane Euthanasia in Animal Shelters Act) by:(1) a practitioner (or, in his or her presence, by     his or her authorized agent),(2) the patient or research subject pursuant to an       order, or(3) a euthanasia technician as defined by the Humane     Euthanasia in Animal Shelters Act.(c) "Agent" means an authorized person who acts on behalf of or at  the direction of a manufacturer, distributor, dispenser, prescriber, or practitioner.  It does not  include a common or contract carrier, public warehouseman or employee of  the carrier or warehouseman.(c-1) "Anabolic Steroids" means any drug or hormonal substance,  chemically and pharmacologically related to testosterone (other than  estrogens, progestins, corticosteroids, and dehydroepiandrosterone),  and includes:(i) 3[beta],17-dihydroxy-5a-androstane,(ii) 3[alpha],17[beta]-dihydroxy-5a-androstane,(iii) 5[alpha]-androstan-3,17-dione,(iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(v) 1-androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(vi) 4-androstenediol(3[beta],17[beta]-dihydroxy-androst-4-ene),(vii) 5-androstenediol(3[beta],17[beta]-dihydroxy-androst-5-ene),(viii) 1-androstenedione([5alpha]-androst-1-en-3,17-dione),(ix) 4-androstenedione(androst-4-en-3,17-dione),(x) 5-androstenedione(androst-5-en-3,17-dione),(xi) bolasterone (7[alpha],17a-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xii) boldenone (17[beta]-hydroxyandrost-1,4,-diene-3-one),(xiii) boldione (androsta-1,4-diene-3,17-dione),(xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one),(xvi) dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-methyl-androst-1,4-dien-3-one),(xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol)(a.k.a., madol),(xviii) [delta]1-dihydrotestosterone (a.k.a.'1-testosterone') (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one),(xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one),(xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene),(xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl-1[beta],17[beta]-dihydroxyandrost-4-en-3-one),(xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one),(xxiv) furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan),(xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one,(xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy-androst-4-en-3-one),(xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxy-estr-4-en-3-one),(xxviii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5-androstan-3-one),(xxix) mesterolone (1amethyl-17[beta]-hydroxy-[5a]-androstan-3-one),(xxx) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one),(xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene),(xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xxxiii) 17[alpha]-methyl-3[beta], 17[beta]-dihydroxy-5a-androstane,(xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane,(xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene),(xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one),(xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one),(xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one),(xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one),(xl) mibolerone (7[alpha],17a-dimethyl-17[beta]-hydroxyestr-4-en-3-one),(xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone(17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl-1-testosterone'),(xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one),(xliii) 19-nor-4-androstenediol (3[beta], 17[beta]-dihydroxyestr-4-ene),(xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]-dihydroxyestr-4-ene),(xlv) 19-nor-5-androstenediol (3[beta], 17[beta]-dihydroxyestr-5-ene),(xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]-dihydroxyestr-5-ene),(xlvii) 19-nor-4,9(10)-androstadienedione(estra-4,9(10)-diene-3,17-dione),(xlviii) 19-nor-4-androstenedione (estr-4-en-3,17-dione),(xlix) 19-nor-5-androstenedione (estr-5-en-3,17-dione),(l) norbolethone (13[beta], 17a-diethyl-17[beta]-hydroxygon-4-en-3-one),(li) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one),(lii) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one),(liii) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one),(liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one),(lv) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one),(lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-(5[alpha]-androstan-3-one),(lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy-(5[alpha]-androst-2-eno[3,2-c]-pyrazole),(lviii) stenbolone (17[beta]-hydroxy-2-methyl-(5[alpha]-androst-1-en-3-one),(lix) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oicacid lactone),(lx) testosterone (17[beta]-hydroxyandrost-4-en-3-one),(lxi) tetrahydrogestrinone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one),(lxii) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one).Any person who is otherwise lawfully in possession of an anabolic  steroid, or who otherwise lawfully manufactures, distributes, dispenses,  delivers, or possesses with intent to deliver an anabolic steroid, which  anabolic steroid is expressly intended for and lawfully allowed to be  administered through implants to livestock or other nonhuman species, and  which is approved by the Secretary of Health and Human Services for such  administration, and which the person intends to administer or have  administered through such implants, shall not be considered to be in  unauthorized possession or to unlawfully manufacture, distribute, dispense,  deliver, or possess with intent to deliver such anabolic steroid for  purposes of this Act.(d) "Administration" means the Drug Enforcement Administration,  United States Department of Justice, or its successor agency.(d-5) "Clinical Director, Prescription Monitoring Program" means a Department of Human Services administrative employee licensed to either prescribe or dispense controlled substances who shall run the clinical aspects of the Department of Human Services Prescription Monitoring Program and its Prescription Information Library.(d-10) "Compounding" means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber's prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing. "Compounding" includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns. Commercially available products may be compounded for dispensing to individual patients only if both of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient's needs and (ii) the prescribing practitioner has requested that the drug be compounded.(e) "Control" means to add a drug or other substance, or immediate  precursor, to a Schedule  whether by  transfer from another Schedule or otherwise.(f) "Controlled Substance" means (i) a drug, substance, immediate  precursor, or synthetic drug in the Schedules of Article II of this Act or (ii) a drug or other substance, or immediate precursor, designated as a controlled substance by the Department through administrative rule. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are  defined or used in the Liquor Control Act of 1934 and the Tobacco Products Tax  Act of 1995.(f-5) "Controlled substance analog" means a substance:(1) the chemical structure of which is substantially     similar to the chemical structure of a controlled substance in Schedule I or II;(2) which has a stimulant, depressant, or     hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or(3) with respect to a particular person, which such     person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II.(g) "Counterfeit substance" means a controlled substance, which, or  the container or labeling of which, without authorization bears the  trademark, trade name, or other identifying mark, imprint, number or  device, or any likeness thereof, of a manufacturer, distributor, or  dispenser other than the person who in fact manufactured, distributed,  or dispensed the substance.(h) "Deliver" or "delivery" means the actual, constructive or  attempted transfer of possession of a controlled substance, with or  without consideration, whether or not there is an agency relationship.  "Deliver" or "delivery" does not include  the donation of drugs to the extent permitted                  under the Illinois Drug Reuse Opportunity Program Act.(i) "Department" means the Illinois Department of Human Services (as  successor to the Department of Alcoholism and Substance Abuse) or its successor agency.(j) (Blank).(k) "Department of Corrections" means the Department of Corrections  of the State of Illinois or its successor agency.(l) "Department of Financial and Professional Regulation" means the Department  of Financial and Professional Regulation of the State of Illinois or its successor agency.(m) "Depressant"  means any drug that (i) causes an overall depression of central nervous system functions, (ii) causes impaired consciousness and awareness,  and (iii) can be habit-forming or  lead to a substance abuse  problem, including but not limited to alcohol, cannabis and its active principles and their analogs, benzodiazepines and their analogs, barbiturates and  their analogs, opioids (natural and synthetic) and their analogs, and chloral hydrate and similar sedative hypnotics.(n) (Blank).(o) "Director" means the Director of the Illinois  State Police  or his or her designated agents.(p) "Dispense" means to deliver a controlled substance to an  ultimate user or research subject by or pursuant to the lawful order of  a prescriber, including the prescribing, administering, packaging,  labeling, or compounding necessary to prepare the substance for that  delivery.(q) "Dispenser" means a practitioner who dispenses.(r) "Distribute" means to deliver, other than by administering or  dispensing, a controlled substance.(s) "Distributor" means a person who distributes.(t) "Drug" means (1) substances recognized as drugs in the official  United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the  United States, or official National Formulary, or any supplement to any  of them; (2) substances intended for use in diagnosis, cure, mitigation,  treatment, or prevention of disease in man or animals; (3) substances  (other than food) intended to affect the structure of any function of  the body of man or animals and (4) substances intended for use as a  component of any article specified in clause (1), (2), or (3) of this  subsection.  It does not include devices or their components, parts, or  accessories.(t-3)  "Electronic health record" or "EHR" means an electronic record of health-related information on an individual that is created, gathered, managed, and consulted by authorized health care clinicians and staff.(t-4) "Emergency medical services personnel" has the meaning ascribed to it in the Emergency Medical Services (EMS) Systems Act.(t-5) "Euthanasia agency" means  an entity certified by the Department of Financial and Professional Regulation for the  purpose of animal euthanasia that holds an animal control facility license or  animal  shelter license under the Animal Welfare Act.  A euthanasia agency is  authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and  Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.(t-10) "Euthanasia drugs" means Schedule II or Schedule III substances  (nonnarcotic controlled substances) that are used by a euthanasia agency for  the purpose of animal euthanasia.(u) "Good faith" means the prescribing or dispensing of a controlled  substance by a practitioner in the regular course of professional  treatment to or for any person who is under his or her treatment for a  pathology or condition other than that individual's physical or  psychological dependence upon or addiction to a controlled substance,  except as provided herein:  and application of the term to a pharmacist  shall mean the dispensing of a controlled substance pursuant to the  prescriber's order which in the professional judgment of the pharmacist  is lawful.  The pharmacist shall be guided by accepted professional  standards including, but not limited to the following, in making the  judgment:(1) lack of consistency of prescriber-patient      relationship,(2) frequency of prescriptions for same drug by one     prescriber for large numbers of patients,(3) quantities beyond those normally prescribed,(4) unusual dosages (recognizing that there may be     clinical circumstances where more or less than the usual dose may be used legitimately),(5) unusual geographic distances between patient,     pharmacist and prescriber,(6) consistent prescribing of habit-forming drugs.(u-0.5) "Hallucinogen" means a drug that causes markedly altered sensory perception leading to hallucinations of any type.(u-1) "Home infusion services" means services provided by a pharmacy in  compounding solutions for direct administration to a patient in a private  residence, long-term care facility, or hospice setting by means of parenteral,  intravenous, intramuscular, subcutaneous, or intraspinal infusion.(u-5) "Illinois State Police" means the State  Police of the State of Illinois, or its successor agency.(v) "Immediate precursor" means a substance:(1) which the Department has found to be and by rule     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;(2) which is an immediate chemical intermediary used     or likely to be used in the manufacture of such controlled substance; and(3) the control of which is necessary to prevent,     curtail or limit the manufacture of such controlled substance.(w) "Instructional activities" means the acts of teaching, educating  or instructing by practitioners using controlled substances within  educational facilities approved by the State Board of Education or  its successor agency.(x) "Local authorities" means a duly organized State, County or  Municipal peace unit or police force.(y) "Look-alike substance" means a substance, other than a controlled  substance which (1) by overall dosage unit appearance, including shape,  color, size, markings or lack thereof, taste, consistency, or any other  identifying physical characteristic of the substance, would lead a reasonable  person to believe that the substance is a controlled substance, or (2) is  expressly or impliedly represented to be a controlled substance or is  distributed under circumstances which would lead a reasonable person to  believe that the substance is a controlled substance. For the purpose of  determining whether the representations made or the circumstances of the  distribution would lead a reasonable person to believe the substance to be  a controlled substance under this clause (2) of subsection (y), the court or  other authority may consider the following factors in addition to any other  factor that may be relevant:(a) statements made by the owner or person in control     of the substance concerning its nature, use or effect;(b) statements made to the buyer or recipient that     the substance may be resold for profit;(c) whether the substance is packaged in a manner     normally used for the illegal distribution of controlled substances;(d) whether the distribution or attempted     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.Clause (1) of this subsection (y) shall not apply to a noncontrolled  substance in its finished dosage form that was initially introduced into  commerce prior to the initial introduction into commerce of a controlled  substance in its finished dosage form which it may substantially resemble.Nothing in this subsection (y) prohibits the dispensing or distributing  of noncontrolled substances by persons authorized to dispense and  distribute controlled substances under this Act, provided that such action  would be deemed to be carried out in good faith under subsection (u) if the  substances involved were controlled substances.Nothing in this subsection (y) or in this Act prohibits the manufacture,  preparation, propagation, compounding, processing, packaging, advertising  or distribution of a drug or drugs by any person registered pursuant to  Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).(y-1) "Mail-order pharmacy" means a pharmacy that is located in a state  of the United States that delivers, dispenses or  distributes, through the United States Postal Service or other common  carrier, to Illinois residents, any substance which requires a prescription.(z) "Manufacture" means the production, preparation, propagation,  compounding, conversion or processing of a controlled substance  other than methamphetamine, either  directly or indirectly, by extraction from substances of natural origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis, and includes any packaging or  repackaging of the substance or labeling of its container, except that  this term does not include:(1) by an ultimate user, the preparation or     compounding of a controlled substance for his or her own use;(2) by a practitioner, or his or her authorized agent     under his or her supervision, the preparation, compounding, packaging, or labeling of a controlled substance:(a) as an incident to his or her administering or         dispensing of a controlled substance in the course of his or her professional practice; or(b) as an incident to lawful research, teaching         or chemical analysis and not for sale; or(3) the packaging, repackaging, or labeling of drugs     only to the extent permitted under the Illinois Drug Reuse Opportunity Program Act.(z-1) (Blank).(z-5) "Medication shopping" means the conduct prohibited under subsection (a) of Section 314.5 of this Act.(z-10) "Mid-level practitioner" means (i) a physician assistant who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches, in accordance with Section 7.5 of the Physician Assistant Practice Act of 1987, (ii) an advanced practice registered nurse who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches or by a podiatric physician,  in accordance with Section 65-40 of the Nurse Practice Act, (iii)  an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act, (iv) an animal euthanasia agency, or (v) a prescribing psychologist.(aa) "Narcotic drug" means any of the following, whether produced  directly or indirectly by extraction from substances of vegetable  origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis:(1) opium, opiates, derivatives of opium and opiates,     including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; however the term "narcotic drug" does not include the isoquinoline alkaloids of opium;(2) (blank);(3) opium poppy and poppy straw;(4) coca leaves, except coca leaves and extracts of     coca leaves from which substantially all of the cocaine and  ecgonine, and their isomers, derivatives and salts, have been removed;(5) cocaine, its salts, optical and geometric     isomers, and salts of isomers;(6) ecgonine, its derivatives, their salts, isomers,     and salts of isomers;(7) any compound, mixture, or preparation which     contains any quantity of any of the substances referred to in subparagraphs (1) through (6).(bb) "Nurse" means a registered nurse licensed under the  Nurse Practice Act.(cc) (Blank).(dd) "Opiate" means any substance having an addiction forming or  addiction sustaining liability similar to morphine or being capable of  conversion into a drug having addiction forming or addiction sustaining  liability.(ee) "Opium poppy" means the plant of the species Papaver  somniferum L., except its seeds.(ee-5) "Oral dosage" means  a tablet, capsule, elixir, or solution or other liquid form of medication intended for administration by mouth, but the term does not include a form of medication intended for buccal, sublingual, or transmucosal administration.(ff) "Parole and Pardon Board" means the Parole and Pardon Board of  the State of Illinois or its successor agency.(gg) "Person" means any individual, corporation, mail-order pharmacy,  government or governmental subdivision or agency, business trust, estate,  trust, partnership or association, or any other entity.(hh) "Pharmacist" means any person who holds a license or certificate of  registration as a registered pharmacist, a local registered pharmacist  or a registered assistant pharmacist under the Pharmacy Practice Act.(ii) "Pharmacy" means any store, ship or other place in which  pharmacy is authorized to be practiced under the Pharmacy Practice Act.(ii-5) "Pharmacy shopping" means the conduct prohibited under subsection (b) of Section 314.5 of this Act.(ii-10) "Physician" (except when the context otherwise requires)   means a person licensed to practice medicine in all of its branches.(jj) "Poppy straw" means all parts, except the seeds, of the opium  poppy, after mowing.(kk) "Practitioner" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, podiatric physician,  veterinarian, scientific investigator, pharmacist, physician assistant,  advanced practice registered nurse,  licensed practical  nurse, registered nurse, emergency medical services personnel, hospital, laboratory, or pharmacy, or other  person licensed, registered, or otherwise lawfully permitted by the  United States or this State to distribute, dispense, conduct research  with respect to, administer or use in teaching or chemical analysis, a  controlled substance in the course of professional practice or research.(ll) "Pre-printed prescription" means a written prescription upon which  the designated drug has been indicated prior to the time of issuance; the term  does not mean a written prescription that is individually generated by  machine or computer in the prescriber's office.(mm) "Prescriber" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, podiatric physician, or  veterinarian who issues a prescription, a physician assistant who  issues a  prescription for a controlled substance  in accordance  with Section 303.05, a written delegation, and a written collaborative agreement required under Section 7.5  of the  Physician Assistant Practice Act of 1987, an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation,  and a written  collaborative agreement under Section 65-35 of the Nurse Practice Act, an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05, or an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn) "Prescription" means a  written, facsimile, or oral  order, or an electronic order that complies with applicable federal requirements,  of  a physician licensed to practice medicine in all its branches,  dentist, podiatric physician or veterinarian for any controlled  substance, of an optometrist in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, of a physician assistant for a  controlled substance  in accordance with Section 303.05, a written delegation, and a written collaborative agreement required under  Section 7.5 of the  Physician Assistant Practice Act of 1987, of an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act who issues a prescription for a  controlled substance in accordance  with  Section 303.05, a written delegation, and a written collaborative agreement under Section 65-35  of the Nurse Practice Act, of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05 when required by law, or of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn-5) "Prescription Information Library" (PIL) means an electronic library that contains reported controlled substance data.(nn-10) "Prescription Monitoring Program" (PMP) means the entity that collects, tracks, and stores reported data on controlled substances and select drugs pursuant to Section 316.(oo) "Production" or "produce" means manufacture, planting,  cultivating, growing, or harvesting of a controlled substance other than methamphetamine.(pp) "Registrant" means every person who is required to register  under Section 302 of this Act.(qq) "Registry number" means the number assigned to each person  authorized to handle controlled substances under the laws of the United  States and of this State.(qq-5) "Secretary" means, as the context requires, either the Secretary of the Department or the Secretary of the Department of Financial and Professional Regulation, and the Secretary's designated agents.(rr) "State" includes the State of Illinois and any state, district,  commonwealth, territory, insular possession thereof, and any area  subject to the legal authority of the United States of America.(rr-5) "Stimulant" means any drug that (i) causes an overall excitation of central nervous system functions,  (ii) causes impaired consciousness and awareness, and (iii) can be habit-forming or lead to a substance abuse problem, including but not limited to amphetamines and their analogs, methylphenidate and its analogs, cocaine, and phencyclidine and its analogs.(rr-10) "Synthetic drug" includes, but is not limited to, any synthetic cannabinoids or piperazines or any synthetic  cathinones as provided for in Schedule I.(ss) "Ultimate user" means a person who lawfully possesses a  controlled substance for his or her own use or for the use of a member of his or her  household or for administering to an animal owned by him or her or by a member  of his or her household.    (Source: P.A. 102-389, eff. 1-1-22.)(Text of Section from P.A. 102-538)Sec. 102. Definitions.   As used in this Act, unless the context  otherwise requires:(a) "Addict" means any person who habitually uses any drug, chemical,  substance or dangerous drug other than alcohol so as to endanger the public  morals, health, safety or welfare or who is so far addicted to the use of a  dangerous drug or controlled substance other than alcohol as to have lost  the power of self control with reference to his or her addiction.(b) "Administer" means the direct application of a controlled  substance, whether by injection, inhalation, ingestion, or any other  means, to the body of a patient, research subject, or animal (as  defined by the Humane Euthanasia in Animal Shelters Act) by:(1) a practitioner (or, in his or her presence, by     his or her authorized agent),(2) the patient or research subject pursuant to an       order, or(3) a euthanasia technician as defined by the Humane     Euthanasia in Animal Shelters Act.(c) "Agent" means an authorized person who acts on behalf of or at  the direction of a manufacturer, distributor, dispenser, prescriber, or practitioner.  It does not  include a common or contract carrier, public warehouseman or employee of  the carrier or warehouseman.(c-1) "Anabolic Steroids" means any drug or hormonal substance,  chemically and pharmacologically related to testosterone (other than  estrogens, progestins, corticosteroids, and dehydroepiandrosterone),  and includes:(i) 3[beta],17-dihydroxy-5a-androstane,(ii) 3[alpha],17[beta]-dihydroxy-5a-androstane,(iii) 5[alpha]-androstan-3,17-dione,(iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(v) 1-androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene),(vi) 4-androstenediol(3[beta],17[beta]-dihydroxy-androst-4-ene),(vii) 5-androstenediol(3[beta],17[beta]-dihydroxy-androst-5-ene),(viii) 1-androstenedione([5alpha]-androst-1-en-3,17-dione),(ix) 4-androstenedione(androst-4-en-3,17-dione),(x) 5-androstenedione(androst-5-en-3,17-dione),(xi) bolasterone (7[alpha],17a-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xii) boldenone (17[beta]-hydroxyandrost-1,4,-diene-3-one),(xiii) boldione (androsta-1,4-diene-3,17-dione),(xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one),(xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one),(xvi) dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-methyl-androst-1,4-dien-3-one),(xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol)(a.k.a., madol),(xviii) [delta]1-dihydrotestosterone (a.k.a.'1-testosterone') (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one),(xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one),(xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene),(xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl-1[beta],17[beta]-dihydroxyandrost-4-en-3-one),(xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one),(xxiv) furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan),(xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one,(xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy-androst-4-en-3-one),(xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxy-estr-4-en-3-one),(xxviii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5-androstan-3-one),(xxix) mesterolone (1amethyl-17[beta]-hydroxy-[5a]-androstan-3-one),(xxx) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one),(xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene),(xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one),(xxxiii) 17[alpha]-methyl-3[beta], 17[beta]-dihydroxy-5a-androstane,(xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane,(xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene),(xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one),(xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one),(xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one),(xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one),(xl) mibolerone (7[alpha],17a-dimethyl-17[beta]-hydroxyestr-4-en-3-one),(xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone(17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl-1-testosterone'),(xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one),(xliii) 19-nor-4-androstenediol (3[beta], 17[beta]-dihydroxyestr-4-ene),(xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]-dihydroxyestr-4-ene),(xlv) 19-nor-5-androstenediol (3[beta], 17[beta]-dihydroxyestr-5-ene),(xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]-dihydroxyestr-5-ene),(xlvii) 19-nor-4,9(10)-androstadienedione(estra-4,9(10)-diene-3,17-dione),(xlviii) 19-nor-4-androstenedione (estr-4-en-3,17-dione),(xlix) 19-nor-5-androstenedione (estr-5-en-3,17-dione),(l) norbolethone (13[beta], 17a-diethyl-17[beta]-hydroxygon-4-en-3-one),(li) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one),(lii) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one),(liii) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one),(liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one),(lv) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one),(lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-(5[alpha]-androstan-3-one),(lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy-(5[alpha]-androst-2-eno[3,2-c]-pyrazole),(lviii) stenbolone (17[beta]-hydroxy-2-methyl-(5[alpha]-androst-1-en-3-one),(lix) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oicacid lactone),(lx) testosterone (17[beta]-hydroxyandrost-4-en-3-one),(lxi) tetrahydrogestrinone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one),(lxii) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one).Any person who is otherwise lawfully in possession of an anabolic  steroid, or who otherwise lawfully manufactures, distributes, dispenses,  delivers, or possesses with intent to deliver an anabolic steroid, which  anabolic steroid is expressly intended for and lawfully allowed to be  administered through implants to livestock or other nonhuman species, and  which is approved by the Secretary of Health and Human Services for such  administration, and which the person intends to administer or have  administered through such implants, shall not be considered to be in  unauthorized possession or to unlawfully manufacture, distribute, dispense,  deliver, or possess with intent to deliver such anabolic steroid for  purposes of this Act.(d) "Administration" means the Drug Enforcement Administration,  United States Department of Justice, or its successor agency.(d-5) "Clinical Director, Prescription Monitoring Program" means a Department of Human Services administrative employee licensed to either prescribe or dispense controlled substances who shall run the clinical aspects of the Department of Human Services Prescription Monitoring Program and its Prescription Information Library.(d-10) "Compounding" means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber's prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing. "Compounding" includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns. Commercially available products may be compounded for dispensing to individual patients only if both of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient's needs and (ii) the prescribing practitioner has requested that the drug be compounded.(e) "Control" means to add a drug or other substance, or immediate  precursor, to a Schedule  whether by  transfer from another Schedule or otherwise.(f) "Controlled Substance" means (i) a drug, substance, immediate  precursor, or synthetic drug in the Schedules of Article II of this Act or (ii) a drug or other substance, or immediate precursor, designated as a controlled substance by the Department through administrative rule. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are  defined or used in the Liquor Control Act of 1934 and the Tobacco Products Tax  Act of 1995.(f-5) "Controlled substance analog" means a substance:(1) the chemical structure of which is substantially     similar to the chemical structure of a controlled substance in Schedule I or II;(2) which has a stimulant, depressant, or     hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or(3) with respect to a particular person, which such     person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II.(g) "Counterfeit substance" means a controlled substance, which, or  the container or labeling of which, without authorization bears the  trademark, trade name, or other identifying mark, imprint, number or  device, or any likeness thereof, of a manufacturer, distributor, or  dispenser other than the person who in fact manufactured, distributed,  or dispensed the substance.(h) "Deliver" or "delivery" means the actual, constructive or  attempted transfer of possession of a controlled substance, with or  without consideration, whether or not there is an agency relationship.(i) "Department" means the Illinois Department of Human Services (as  successor to the Department of Alcoholism and Substance Abuse) or its successor agency.(j) (Blank).(k) "Department of Corrections" means the Department of Corrections  of the State of Illinois or its successor agency.(l) "Department of Financial and Professional Regulation" means the Department  of Financial and Professional Regulation of the State of Illinois or its successor agency.(m) "Depressant"  means any drug that (i) causes an overall depression of central nervous system functions, (ii) causes impaired consciousness and awareness,  and (iii) can be habit-forming or  lead to a substance abuse  problem, including but not limited to alcohol, cannabis and its active principles and their analogs, benzodiazepines and their analogs, barbiturates and  their analogs, opioids (natural and synthetic) and their analogs, and chloral hydrate and similar sedative hypnotics.(n) (Blank).(o) "Director" means the Director of the Illinois  State Police  or his or her designated agents.(p) "Dispense" means to deliver a controlled substance to an  ultimate user or research subject by or pursuant to the lawful order of  a prescriber, including the prescribing, administering, packaging,  labeling, or compounding necessary to prepare the substance for that  delivery.(q) "Dispenser" means a practitioner who dispenses.(r) "Distribute" means to deliver, other than by administering or  dispensing, a controlled substance.(s) "Distributor" means a person who distributes.(t) "Drug" means (1) substances recognized as drugs in the official  United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the  United States, or official National Formulary, or any supplement to any  of them; (2) substances intended for use in diagnosis, cure, mitigation,  treatment, or prevention of disease in man or animals; (3) substances  (other than food) intended to affect the structure of any function of  the body of man or animals and (4) substances intended for use as a  component of any article specified in clause (1), (2), or (3) of this  subsection.  It does not include devices or their components, parts, or  accessories.(t-3)  "Electronic health record" or "EHR" means an electronic record of health-related information on an individual that is created, gathered, managed, and consulted by authorized health care clinicians and staff.(t-4) "Emergency medical services personnel" has the meaning ascribed to it in the Emergency Medical Services (EMS) Systems Act.(t-5) "Euthanasia agency" means  an entity certified by the Department of Financial and Professional Regulation for the  purpose of animal euthanasia that holds an animal control facility license or  animal  shelter license under the Animal Welfare Act.  A euthanasia agency is  authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and  Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.(t-10) "Euthanasia drugs" means Schedule II or Schedule III substances  (nonnarcotic controlled substances) that are used by a euthanasia agency for  the purpose of animal euthanasia.(u) "Good faith" means the prescribing or dispensing of a controlled  substance by a practitioner in the regular course of professional  treatment to or for any person who is under his or her treatment for a  pathology or condition other than that individual's physical or  psychological dependence upon or addiction to a controlled substance,  except as provided herein:  and application of the term to a pharmacist  shall mean the dispensing of a controlled substance pursuant to the  prescriber's order which in the professional judgment of the pharmacist  is lawful.  The pharmacist shall be guided by accepted professional  standards including, but not limited to the following, in making the  judgment:(1) lack of consistency of prescriber-patient      relationship,(2) frequency of prescriptions for same drug by one     prescriber for large numbers of patients,(3) quantities beyond those normally prescribed,(4) unusual dosages (recognizing that there may be     clinical circumstances where more or less than the usual dose may be used legitimately),(5) unusual geographic distances between patient,     pharmacist and prescriber,(6) consistent prescribing of habit-forming drugs.(u-0.5) "Hallucinogen" means a drug that causes markedly altered sensory perception leading to hallucinations of any type.(u-1) "Home infusion services" means services provided by a pharmacy in  compounding solutions for direct administration to a patient in a private  residence, long-term care facility, or hospice setting by means of parenteral,  intravenous, intramuscular, subcutaneous, or intraspinal infusion.(u-5) "Illinois State Police" means the Illinois State  Police or its successor agency.(v) "Immediate precursor" means a substance:(1) which the Department has found to be and by rule     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;(2) which is an immediate chemical intermediary used     or likely to be used in the manufacture of such controlled substance; and(3) the control of which is necessary to prevent,     curtail or limit the manufacture of such controlled substance.(w) "Instructional activities" means the acts of teaching, educating  or instructing by practitioners using controlled substances within  educational facilities approved by the State Board of Education or  its successor agency.(x) "Local authorities" means a duly organized State, County or  Municipal peace unit or police force.(y) "Look-alike substance" means a substance, other than a controlled  substance which (1) by overall dosage unit appearance, including shape,  color, size, markings or lack thereof, taste, consistency, or any other  identifying physical characteristic of the substance, would lead a reasonable  person to believe that the substance is a controlled substance, or (2) is  expressly or impliedly represented to be a controlled substance or is  distributed under circumstances which would lead a reasonable person to  believe that the substance is a controlled substance. For the purpose of  determining whether the representations made or the circumstances of the  distribution would lead a reasonable person to believe the substance to be  a controlled substance under this clause (2) of subsection (y), the court or  other authority may consider the following factors in addition to any other  factor that may be relevant:(a) statements made by the owner or person in control     of the substance concerning its nature, use or effect;(b) statements made to the buyer or recipient that     the substance may be resold for profit;(c) whether the substance is packaged in a manner     normally used for the illegal distribution of controlled substances;(d) whether the distribution or attempted     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.Clause (1) of this subsection (y) shall not apply to a noncontrolled  substance in its finished dosage form that was initially introduced into  commerce prior to the initial introduction into commerce of a controlled  substance in its finished dosage form which it may substantially resemble.Nothing in this subsection (y) prohibits the dispensing or distributing  of noncontrolled substances by persons authorized to dispense and  distribute controlled substances under this Act, provided that such action  would be deemed to be carried out in good faith under subsection (u) if the  substances involved were controlled substances.Nothing in this subsection (y) or in this Act prohibits the manufacture,  preparation, propagation, compounding, processing, packaging, advertising  or distribution of a drug or drugs by any person registered pursuant to  Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).(y-1) "Mail-order pharmacy" means a pharmacy that is located in a state  of the United States that delivers, dispenses or  distributes, through the United States Postal Service or other common  carrier, to Illinois residents, any substance which requires a prescription.(z) "Manufacture" means the production, preparation, propagation,  compounding, conversion or processing of a controlled substance  other than methamphetamine, either  directly or indirectly, by extraction from substances of natural origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis, and includes any packaging or  repackaging of the substance or labeling of its container, except that  this term does not include:(1) by an ultimate user, the preparation or     compounding of a controlled substance for his or her own use; or(2) by a practitioner, or his or her authorized agent     under his or her supervision, the preparation, compounding, packaging, or labeling of a controlled substance:(a) as an incident to his or her administering or         dispensing of a controlled substance in the course of his or her professional practice; or(b) as an incident to lawful research, teaching         or chemical analysis and not for sale.(z-1) (Blank).(z-5) "Medication shopping" means the conduct prohibited under subsection (a) of Section 314.5 of this Act.(z-10) "Mid-level practitioner" means (i) a physician assistant who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches, in accordance with Section 7.5 of the Physician Assistant Practice Act of 1987, (ii) an advanced practice registered nurse who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches or by a podiatric physician,  in accordance with Section 65-40 of the Nurse Practice Act, (iii)  an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act, (iv) an animal euthanasia agency, or (v) a prescribing psychologist.(aa) "Narcotic drug" means any of the following, whether produced  directly or indirectly by extraction from substances of vegetable  origin,  or independently by means of chemical synthesis, or by a combination of  extraction and chemical synthesis:(1) opium, opiates, derivatives of opium and opiates,     including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; however the term "narcotic drug" does not include the isoquinoline alkaloids of opium;(2) (blank);(3) opium poppy and poppy straw;(4) coca leaves, except coca leaves and extracts of     coca leaves from which substantially all of the cocaine and  ecgonine, and their isomers, derivatives and salts, have been removed;(5) cocaine, its salts, optical and geometric     isomers, and salts of isomers;(6) ecgonine, its derivatives, their salts, isomers,     and salts of isomers;(7) any compound, mixture, or preparation which     contains any quantity of any of the substances referred to in subparagraphs (1) through (6).(bb) "Nurse" means a registered nurse licensed under the  Nurse Practice Act.(cc) (Blank).(dd) "Opiate" means any substance having an addiction forming or  addiction sustaining liability similar to morphine or being capable of  conversion into a drug having addiction forming or addiction sustaining  liability.(ee) "Opium poppy" means the plant of the species Papaver  somniferum L., except its seeds.(ee-5) "Oral dosage" means  a tablet, capsule, elixir, or solution or other liquid form of medication intended for administration by mouth, but the term does not include a form of medication intended for buccal, sublingual, or transmucosal administration.(ff) "Parole and Pardon Board" means the Parole and Pardon Board of  the State of Illinois or its successor agency.(gg) "Person" means any individual, corporation, mail-order pharmacy,  government or governmental subdivision or agency, business trust, estate,  trust, partnership or association, or any other entity.(hh) "Pharmacist" means any person who holds a license or certificate of  registration as a registered pharmacist, a local registered pharmacist  or a registered assistant pharmacist under the Pharmacy Practice Act.(ii) "Pharmacy" means any store, ship or other place in which  pharmacy is authorized to be practiced under the Pharmacy Practice Act.(ii-5) "Pharmacy shopping" means the conduct prohibited under subsection (b) of Section 314.5 of this Act.(ii-10) "Physician" (except when the context otherwise requires)   means a person licensed to practice medicine in all of its branches.(jj) "Poppy straw" means all parts, except the seeds, of the opium  poppy, after mowing.(kk) "Practitioner" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, podiatric physician,  veterinarian, scientific investigator, pharmacist, physician assistant,  advanced practice registered nurse,  licensed practical  nurse, registered nurse, emergency medical services personnel, hospital, laboratory, or pharmacy, or other  person licensed, registered, or otherwise lawfully permitted by the  United States or this State to distribute, dispense, conduct research  with respect to, administer or use in teaching or chemical analysis, a  controlled substance in the course of professional practice or research.(ll) "Pre-printed prescription" means a written prescription upon which  the designated drug has been indicated prior to the time of issuance; the term  does not mean a written prescription that is individually generated by  machine or computer in the prescriber's office.(mm) "Prescriber" means a physician licensed to practice medicine in all  its branches, dentist, optometrist, prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, podiatric physician, or  veterinarian who issues a prescription, a physician assistant who  issues a  prescription for a controlled substance  in accordance  with Section 303.05, a written delegation, and a written collaborative agreement required under Section 7.5  of the  Physician Assistant Practice Act of 1987, an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation,  and a written  collaborative agreement under Section 65-35 of the Nurse Practice Act, an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05, or an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn) "Prescription" means a  written, facsimile, or oral  order, or an electronic order that complies with applicable federal requirements,  of  a physician licensed to practice medicine in all its branches,  dentist, podiatric physician or veterinarian for any controlled  substance, of an optometrist in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a prescribing psychologist licensed under Section 4.2 of the Clinical Psychologist Licensing Act with prescriptive authority delegated under Section 4.3 of the Clinical Psychologist Licensing Act, of a physician assistant for a  controlled substance  in accordance with Section 303.05, a written delegation, and a written collaborative agreement required under  Section 7.5 of the  Physician Assistant Practice Act of 1987, of an advanced practice registered  nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act who issues a prescription for a  controlled substance in accordance  with  Section 303.05, a written delegation, and a written collaborative agreement under Section 65-35  of the Nurse Practice Act, of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has been granted authority to prescribe by a hospital affiliate in accordance with Section 65-45 of the Nurse Practice Act and in accordance with Section 303.05 when required by law, or of an advanced practice registered nurse certified as a nurse practitioner, nurse midwife, or clinical nurse specialist who has full practice authority pursuant to Section 65-43 of the Nurse Practice Act.(nn-5) "Prescription Information Library" (PIL) means an electronic library that contains reported controlled substance data.(nn-10) "Prescription Monitoring Program" (PMP) means the entity that collects, tracks, and stores reported data on controlled substances and select drugs pursuant to Section 316.(oo) "Production" or "produce" means manufacture, planting,  cultivating, growing, or harvesting of a controlled substance other than methamphetamine.(pp) "Registrant" means every person who is required to register  under Section 302 of this Act.(qq) "Registry number" means the number assigned to each person  authorized to handle controlled substances under the laws of the United  States and of this State.(qq-5) "Secretary" means, as the context requires, either the Secretary of the Department or the Secretary of the Department of Financial and Professional Regulation, and the Secretary's designated agents.(rr) "State" includes the State of Illinois and any state, district,  commonwealth, territory, insular possession thereof, and any area  subject to the legal authority of the United States of America.(rr-5) "Stimulant" means any drug that (i) causes an overall excitation of central nervous system functions,  (ii) causes impaired consciousness and awareness, and (iii) can be habit-forming or lead to a substance abuse problem, including but not limited to amphetamines and their analogs, methylphenidate and its analogs, cocaine, and phencyclidine and its analogs.(rr-10) "Synthetic drug" includes, but is not limited to, any synthetic cannabinoids or piperazines or any synthetic  cathinones as provided for in Schedule I.(ss) "Ultimate user" means a person who lawfully possesses a  controlled substance for his or her own use or for the use of a member of his or her  household or for administering to an animal owned by him or her or by a member  of his or her household.    (Source: P.A. 102-538, eff. 8-20-21.)